Latest Breaking News On - Professor tony kouzarides - Page 1 : comparemela.com

Two Hundred Approved Drugs Found to be Effective Against COVID-19

Two Hundred Approved Drugs Found to be Effective Against COVID-19
medindia.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medindia.net Daily Mail and Mail on Sunday newspapers.

Tony-kouzarides
Professor-tony-kouzarides

Invizius Announces Successful Series A Financing to Develop Anti-Inflammatory Treatment for Haemodialysis

Share this article Share this article MOTHERWELL, Scotland, May 6, 2021 /PRNewswire/ Invizius Limited ( Invizius ), a biotechnology company developing treatments to suppress unwanted innate immune responses, today announces that it has closed Series A financing of £5.3 million. The financing was led by existing investors Mercia, Downing Ventures, Old College Capital, Scottish Enterprise, Solvay Ventures and new investors Calculus Capital and experienced life science entrepreneur and investor, Dr Jonathan Milner. Although already over-subscribed, the company s Series A remains open to other investors until June 2021. Invizius will use the financing to complete a First-in-Man safety study in 2022 of its H-Guard ® Priming Solution to reduce the life-threatening inflammatory effects of haemodialysis.

United-states
Paris
France-general
France
United-kingdom
Israel
Leicester
Cambridge
Cambridgeshire
London
City-of
Edinburgh

Researchers develop new class of cancer drug with potential to treat leukaemia

Scientists have hailed “a new era for cancer therapeutics” as they take a step towards developing a new drug for treating a rare blood disorder, myeloid leukaemia. University of Cambridge researchers have reported a new approach to cancer treatment that targets enzymes which play a key role in translating DNA into proteins and could lead to a new class of cancer drugs. Genetic code is written in DNA, but in order to generate proteins – molecules that are vital to the function of living organisms – DNA first needs to be converted into RNA. The production of proteins is controlled by enzymes, which make chemical changes to RNA.

Cambridge
Cambridgeshire
United-kingdom
Tony-kouzarides
Konstantinos-tzelepis
Gurdon-institute
Wellcome-sanger-institute
University-of-cambridge
Kay-kendall-leukaemia-fund
Milner-therapeutics-institute
Cancer-research-united-kingdom
Wellcome

'New era' of cancer drug with potential to treat leukaemia hailed by scientists

'New era' of cancer drug with potential to treat leukaemia hailed by scientists
plymouthherald.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plymouthherald.co.uk Daily Mail and Mail on Sunday newspapers.

Cambridge
Cambridgeshire
United-kingdom
Tony-kouzarides
Konstantinos-tzelepis
Gurdon-institute
Wellcome-sanger-institute
University-of-cambridge
Kay-kendall-leukaemia-fund
Milner-therapeutics-institute
Cancer-research-united-kingdom
Wellcome

Scientists develop new class of cancer drug with potential to treat leukaemia

E-Mail Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published today in Nature, Cambridge researchers report a new approach to cancer treatment that targets enzymes which play a key role in translating DNA into proteins and which could lead to a new class of cancer drugs. Our genetic code is written in DNA, but in order to generate proteins - molecules that are vital to the function of living organisms - DNA first needs to be converted into RNA. The production of proteins is controlled by enzymes, which make chemical changes to RNA. Occasionally these enzymes become mis-regulated, being produced in over-abundance.

Cambridge
Cambridgeshire
United-kingdom
Tony-kouzarides
Konstantinos-tzelepis
Michelle-mitchell
Gurdon-institute
Wellcome-sanger-institute
University-of-cambridge
Kay-kendall-leukaemia-fund
Cancer-research-united-kingdom
Milner-therapeutics-institute